Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study.
Saved in:
| Title: | Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study. |
|---|---|
| Authors: | Reinhold WC; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., Marangoni E; Translational Research Department, Institut Curie, PSL University, Paris, France., Elloumi F; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., Montagne R; CBIO-Centre for Computational Biology, Institut Curie, INSERM, Mines ParisTech, Paris, France., Varma S; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.; HiThru Analytics LLC, Princeton, New Jersey., Wang Y; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.; ICF International Inc., Fairfax, Virginia., Rezai K; Institut Curie, Département de Radio-Pharmacologie, Saint-Cloud, France., Morriset L; Translational Research Department, Institut Curie, PSL University, Paris, France., Dahmani A; Translational Research Department, Institut Curie, PSL University, Paris, France., El Botty R; Translational Research Department, Institut Curie, PSL University, Paris, France., Huguet L; Translational Research Department, Institut Curie, PSL University, Paris, France., Mizunuma M; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., Takebe N; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland., Huguet S; Institut Curie, Département de Radio-Pharmacologie, Saint-Cloud, France., Luna A; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.; Computational Biology Branch, National Library of Medicine, NIH, Bethesda, Maryland., Pommier Y; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. |
| Source: | Cancer research communications [Cancer Res Commun] 2025 Feb 01; Vol. 5 (2), pp. 375-388. |
| Publication Type: | Journal Article; Research Support, N.I.H., Intramural |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39932272 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Reinhold+WC%22">Reinhold WC</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Marangoni+E%22">Marangoni E</searchLink>; Translational Research Department, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Elloumi+F%22">Elloumi F</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Montagne+R%22">Montagne R</searchLink>; CBIO-Centre for Computational Biology, Institut Curie, INSERM, Mines ParisTech, Paris, France.<br /><searchLink fieldCode="AU" term="%22Varma+S%22">Varma S</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.; HiThru Analytics LLC, Princeton, New Jersey.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.; ICF International Inc., Fairfax, Virginia.<br /><searchLink fieldCode="AU" term="%22Rezai+K%22">Rezai K</searchLink>; Institut Curie, Département de Radio-Pharmacologie, Saint-Cloud, France.<br /><searchLink fieldCode="AU" term="%22Morriset+L%22">Morriset L</searchLink>; Translational Research Department, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Dahmani+A%22">Dahmani A</searchLink>; Translational Research Department, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22El+Botty+R%22">El Botty R</searchLink>; Translational Research Department, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Huguet+L%22">Huguet L</searchLink>; Translational Research Department, Institut Curie, PSL University, Paris, France.<br /><searchLink fieldCode="AU" term="%22Mizunuma+M%22">Mizunuma M</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Takebe+N%22">Takebe N</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Huguet+S%22">Huguet S</searchLink>; Institut Curie, Département de Radio-Pharmacologie, Saint-Cloud, France.<br /><searchLink fieldCode="AU" term="%22Luna+A%22">Luna A</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland.; Computational Biology Branch, National Library of Medicine, NIH, Bethesda, Maryland.<br /><searchLink fieldCode="AU" term="%22Pommier+Y%22">Pommier Y</searchLink>; Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918281580506676%22">Cancer research communications</searchLink> [Cancer Res Commun] 2025 Feb 01; Vol. 5 (2), pp. 375-388. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Intramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918281580506676 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2767-9764 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227679764%22">27679764 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res Commun <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39932272 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/2767-9764.CRC-24-0435 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 375 Titles: – TitleFull: Acetalax and Bisacodyl for the Treatment of Triple-Negative Breast Cancer: A Combined Molecular and Preclinical Study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Reinhold WC – PersonEntity: Name: NameFull: Marangoni E – PersonEntity: Name: NameFull: Elloumi F – PersonEntity: Name: NameFull: Montagne R – PersonEntity: Name: NameFull: Varma S – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Rezai K – PersonEntity: Name: NameFull: Morriset L – PersonEntity: Name: NameFull: Dahmani A – PersonEntity: Name: NameFull: El Botty R – PersonEntity: Name: NameFull: Huguet L – PersonEntity: Name: NameFull: Mizunuma M – PersonEntity: Name: NameFull: Takebe N – PersonEntity: Name: NameFull: Huguet S – PersonEntity: Name: NameFull: Luna A – PersonEntity: Name: NameFull: Pommier Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 02 Text: 2025 Feb 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2767-9764 Numbering: – Type: volume Value: 5 – Type: issue Value: 2 Titles: – TitleFull: Cancer research communications Type: main |
| ResultId | 1 |